Cetuximab, paclitaxel combo active in urothelial cancer
(HealthDay)—The monoclonal antibody against epidermal growth factor receptor (EGFR), cetuximab, augments the antitumor activity of paclitaxel in patients with previously treated urothelial cancer, according ...
Cancer
Aug 29, 2012 |
not rated yet |
0
Renal denervation achieves significant and sustained blood pressure reduction
Renal denervation leads to significant and sustained blood pressure reduction for up to 18 months in patients with treatment resistant hypertension, according to research presented at ESC Congress 2012. The new clinical data ...
Cardiology
Aug 27, 2012 |
not rated yet |
0
Typical IBD patients not represented in research studies
Major randomized controlled trials of new therapies for inflammatory bowel disease (IBD) are conducted on patients who are not typical of those who physicians see in day-to-day practice, according to a new study in Clinical Ga ...
Diseases, Conditions, Syndromes
Aug 22, 2012 |
not rated yet |
0
Corticosteroids not effective for treating acute sinusitis
Corticosteroids, frequently prescribed to alleviate acute sinusitis, show no clinical benefit in treating the condition, according to a randomized controlled trial published in CMAJ (Canadian Medical Association Journal). ...
Diseases, Conditions, Syndromes
Aug 07, 2012 |
not rated yet |
0
Study examines effects of growth hormone-releasing hormone on cognitive function
Treatment with growth hormone-releasing hormone appears to be associated with favorable cognitive effects among both adults with mild cognitive impairment and healthy older adults, according to a randomized clinical trial ...
Neuroscience
Aug 06, 2012 |
not rated yet |
0
New HPTN 052 study results reveal additional benefits of early HIV treatment
Study results released today by the HIV Prevention Trials Network (HPTN) show additional benefits of early antiretroviral therapy (ART) in HIV clinical outcomes. Expanded analysis of HPTN 052 study data, presented today at ...
HIV & AIDS
Jul 26, 2012 |
not rated yet |
0
Benefits of prostate-specific antigen testing remain unclear
(HealthDay) -- It remains unclear whether the benefits of prostate-specific antigen (PSA) testing outweigh the harms, but evidence suggests that men with a longer life expectancy may benefit from testing, ...
Cancer
Jul 20, 2012 |
not rated yet |
3
|
Tests ID'd for use in outcome assessment of spinal stenosis
(HealthDay) -- For patients with lumbar spinal stenosis the Oswestry Disability Index, Modified Swiss Spinal Stenosis Scale (SSS), and Patient Specific Functional Scale have been shown to possess adequate ...
Diseases, Conditions, Syndromes
Jul 12, 2012 |
not rated yet |
0
Modern medicine and patients' well being
(Medical Xpress) -- A new study has found that although there has been an explosion in the scientific underpinning of modern medicine, gaps still remain in our knowledge when it comes to clinicians looking ...
Health
Jul 06, 2012 |
not rated yet |
0
Atrial fibrillation: Flec-SL trial proves efficacy of short-term antiarrhythmic drug treatment
Atrial fibrillation (AF) is the most frequently sustained arrhythmia of the heart. It affects several million people in Europe. AF causes a loss of contraction in the atria and gives rise to heart failure. Moreover, it is ...
Cardiology
Jun 18, 2012 |
not rated yet |
0
Intravesical chondroitin sulfate of little benefit in cystitis
(HealthDay) -- Intravesical sodium chondroitin sulfate is not recommended for the treatment of interstitial cystitis/bladder pain syndrome (IC/BPS) in women as it produces only minor improvements in symptoms ...
Diseases, Conditions, Syndromes
Jun 06, 2012 |
not rated yet |
0
For advanced prostate cancer, new drug slows disease
A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients ...
Cancer
Jun 02, 2012 |
not rated yet |
0
|
Canada should significantly increase its funding of randomized clinical trials
Large randomized controlled trials (RCTs) are critical for determining effectiveness of medical therapies, tests and procedures. Yet Canada provides scant support for these studies compared with other western countries, states ...
Other
May 22, 2012 |
not rated yet |
0
Low-dose CT screening may benefit individuals at increased risk for lung cancer
Peter B. Bach, M.D., of the Memorial Sloan-Kettering Cancer Center, New York, and colleagues conducted a systematic review to examine the evidence regarding the benefits and harms of low-dose computerized tomography (LDCT) ...
Cancer
May 20, 2012 |
not rated yet |
0
Experts call for clinical trials to test non-skeletal benefits of vitamin D
The Endocrine Society's new scientific statement published online today represents the first comprehensive evaluation of both the basic and clinical evidence related to the non-skeletal effects of vitamin D. The statement ...
Health
May 18, 2012 |
not rated yet |
0
